INSPIRE VETERINARY PARTNERS, INC.
inspirevet.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q3 FY2025 10-Q, filed Nov 12, 2025. Its latest SEC filing is a 25-NSE from Jun 4, 2026.
10-Q for Q3 FY2025, filed Nov 12, 2025
The sections below describe the company as of the FY2024 annual report.
What Did They Do?
Operates veterinary hospitals that provide general and surgical care for companion animals, including dogs, cats and horses.
10-K for FY2024, filed Mar 31, 2025Inspire Veterinary owns and operates veterinary hospitals throughout the United States. The Company specializes in small animal general…View ↗
Services provided at the Company’s hospitals include preventive care for companion animals consisting of annual health exams which include…View ↗
Services provided at owned hospitals include preventive care for companion animals consisting of annual health exams which include…View ↗
How Did They Make Money?
Pet owners pay for veterinary services when care is completed, typically at the point of sale or upon completion. They pay for products when they complete a transaction and receive the product.
10-K for FY2024, filed Mar 31, 2025The Company recognizes service revenue from veterinary care services once the service is completed, as this is when the customer has the…View ↗
-
10-K for FY2024, filed Mar 31, 2025
FY2024 revenue by product or service ↗
$16.6M
-
10-K for FY2024, filed Mar 31, 2025
$16.6M ↗
| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Service revenue
Sold outright
10-K for FY2024, filed Mar 31, 2025 |
73% |
Service revenue, FY2024
$12.2M Sources
|
Sold outright |
|
Product revenue
Sold outright
10-K for FY2024, filed Mar 31, 2025 |
27% |
Product revenue, FY2024
$4.4M Sources
|
Sold outright |
Who Were Their Customers?
Pet owners receive care and buy products at the company’s veterinary hospitals and clinics.
10-K for FY2024, filed Mar 31, 2025
Did Revenues Turn Into Profits?
No. It lost $14.3M in FY2024.
10-K for FY2024, filed Mar 31, 2025
−$9MView ↗
10-K for FY2024, filed Mar 31, 2025
−$14.3MView ↗
10-K for FY2024, filed Mar 31, 2025
−$10.2MView ↗
How Were They Changing?
- Net income
-
Sources
10-Q for Q3 FY2025, filed Nov 12, 2025
−$2.5MView ↗
- ▼ −28% (Loss)
- vs −$3.5M in Q3 FY2024
10-Q for Q3 FY2025, filed Nov 12, 2025
Open tableView ↗
-
Jan 21, 2026
Nasdaq delisted the company’s stock, which began trading on OTCQB.
Trading on Nasdaq was suspended, and the stock began trading on the OTCQB Venture Market under IVPR.
Sources
8-K, filed Jan 21, 2026
On January 20, 2026, the Panel denied the Company’s request to continue its listing on Nasdaq. The Common Stock was suspended from trading…View ↗
Who Did They Compete With?
Competes with Mars, NVA, Pathway/Thrive, VetcCor, Southern Vet Partners, Community Veterinary Partners, Compassion First, and Vetspire
10-K for FY2024, filed Mar 31, 2025Competitors range in size from the largest such as Mars and NVA, which collectively own approximately 4,000 hospitals, to other national…View ↗
Loading...
